China Advanced Maternal Age IVF Success Rate: Age-Stratified Data and Key Influencing Factors

What is the IVF success rate for advanced maternal age in China? Based on clinical data from domestic reproductive centers, this article analyzes the live birth rate per transfer cycle for women aged 35 to over 45, explaining the impact of age, AMH, egg quality, and chromosomal abnormalities on success rates, helping older individuals scientifically understand the realities and reasonable expectations of IVF.

China Advanced Maternal Age IVF Success Rate: Age-Stratified Data and Key Influencing Factors
IVF 2026-07-07

Opening: Real Consultation Scenario

A 43-year-old woman walks into the clinic, clutching a stack of test reports. After sitting down, she spreads the reports on the table one by one — AMH 0.6 ng/mL, FSH 13.8 IU/L, vaginal ultrasound showing an antral follicle count of 2 on each side. She had undergone one IVF cycle at another hospital, resulting in 3 eggs retrieved, 2 fertilized, but ultimately no transferable embryos. She looked up and asked me her first question: "Doctor, is there still hope for me to do IVF? What is the actual success rate?"

This question appears almost daily in reproductive clinics. For women of advanced maternal age, the IVF success rate is not a question that can be answered with a single number. It is directly related to age, ovarian reserve, embryo chromosomal status, and the laboratory standards of the medical institution. Below, we break down this issue clearly from the perspectives of clinical data and decision-making pathways.

China Advanced Maternal Age IVF Success Rate: Age-Stratified Data

Using the live birth rate per single embryo transfer as the benchmark, the clinical statistical results from major domestic reproductive centers (including some national key assisted reproduction laboratories) are shown in the table below. It should be noted that these data come from aggregated statistics of multiple centers; individual differences objectively exist, and specific data for each center may fluctuate due to different patient selection criteria.

Age Group Live Birth Rate per Transfer Cycle (Approx.) Egg Chromosomal Aneuploidy Rate (Approx.) Notes
Under 35 40% – 50% 20% – 30% Non-advanced age group, reference baseline
35 – 37 30% – 40% 30% – 40% Success rate begins to decline
38 – 40 20% – 30% 40% – 55% Clinically advanced age, chromosomal risk increases
41 – 42 10% – 15% 60% – 70% Live birth rate per transfer cycle significantly decreases
43 – 44 5% – 10% 75% – 85% Cumulative cycle strategy should be considered
Over 45 < 5% 85% – 95% Evaluation of egg donation options is usually recommended

From the table above, it is直观地 seen: For each additional year of age, the rate of chromosomal abnormalities increases exponentially, not linearly. This is the most fundamental biological reason for the decline in IVF success rates with advanced maternal age.

Differences and Strategies for Different Age Groups

38–40 Years Old: The "Watershed" of Clinical Advanced Age

Ovarian reserve function begins to decline significantly at this stage, but a considerable number of women can still obtain chromosomally normal embryos. The key tests are AMH + Antral Follicle Count + Basal FSH. A combined assessment of these three is more reliable than any single one. If AMH is above 1.0 ng/mL and the total antral follicle count on both sides is 5 or more, a conventional ovarian stimulation protocol can be considered, and it is recommended to perform embryo chromosomal screening (PGT-A).

41–42 Years Old: Adjusting Expectations

For patients in this age group, I usually inform them directly: the live birth rate per single transfer is around 10-15%, but if 2-3 chromosomally normal embryos can be accumulated, the cumulative live birth rate can increase to 30-40%. Therefore, the key is to accumulate embryos, rather than pursuing success in a single attempt. Mental and financial preparation for multiple stimulation cycles is necessary in advance.

43–44 Years Old: Preferred Strategy Needs Adjustment

Ovarian reserve at this stage is mostly low, with a median AMH between 0.4-0.8 ng/mL. With conventional ovarian stimulation, the number of eggs retrieved is usually only 1-3, and the probability of forming a blastocyst suitable for biopsy is even lower. Clinically, mild stimulation or natural cycle protocols are more recommended, aiming to "obtain 1 high-quality embryo per cycle." After screening via PGT-A, accumulate at least 1-2 normal embryos before transfer. If no chromosomally normal embryos are obtained after 2-3 consecutive cycles, other options should be considered.

Over 45 Years Old: Reality and Decision-Making

The live birth rate is less than 5%, and the miscarriage rate after pregnancy exceeds 70%. From a medical perspective, the cost-effectiveness of using one's own eggs for IVF at this age is very low. Formal reproductive centers in China require thorough informed consent before the procedure, including the option of egg donation. If a patient insists on using her own eggs, a diagnostic egg retrieval is generally recommended first to assess egg quality and embryo development potential before deciding whether to continue.

Why Does Age Have Such a Significant Impact on Success Rate?

The fundamental reason lies not in the uterus, but in the egg. Oocytes are all present in the ovaries at birth and are not renewed or regenerated. With increasing age, mitochondrial function within the egg declines, and the rate of spindle assembly abnormalities increases, leading to a rising annual risk of errors in meiosis. This is the source of chromosomal aneuploidy — having an extra or missing a chromosome.

Over 90% of eggs from a 45-year-old woman are chromosomally abnormal. Even if such an egg is fertilized and forms an embryo, it is difficult to implant, or it will miscarry early after implantation. Additionally, endometrial receptivity also mildly declines after age 40, but compared to the impact of egg quality, the uterine factor plays a much smaller role.

Doctor's Perspective: Many advanced-age patients ask, "My AMH is still normal, so why is the success rate still low?" AMH reflects egg quantity, not quality. Even if a 45-year-old has an AMH of 1.2 ng/mL, the egg chromosomal abnormality rate is still above 85%. Quantity and quality are two different things; this is the first hurdle in understanding IVF success rates for advanced maternal age.

Key Diagnostic Indicators: How to Assess Your Situation?

The following four tests are essential evaluations for advanced-age women before undergoing IVF, each with specific clinical significance.

Test Item Normal Reference Range Significance for Advanced Age What to Note
AMH ≥1.0 ng/mL (varies slightly between labs) Reflects ovarian reserve quantity; lower AMH means fewer eggs retrieved Low AMH doesn't mean it's impossible, just that the protocol needs adjustment
Basal FSH (Day 2-3 of cycle) ≤10 IU/L Elevated FSH indicates decreased ovarian reserve and potentially poor response FSH 10-15 may still yield eggs; >20 is usually not very meaningful
Antral Follicle Count (AFC) Total 5-10 on both sides AFC is directly related to the number of eggs retrieved and is more intuitive than AMH Must be performed by an experienced ultrasound operator
Thyroid Function + Vitamin D TSH < 2.5 mIU/L, VD > 30 ng/mL Thyroid abnormalities and VD deficiency can affect embryo implantation These two indicators are adjustable; optimization before starting the cycle is recommended

Additionally, chromosomal karyotype analysis and hysteroscopy are also easily overlooked items for the advanced-age population. The former can rule out issues like balanced chromosomal translocations in the couple, while the latter can check for endometrial polyps, adhesions, or chronic endometritis — which are not uncommon in older women.

Easily Overlooked Details

  • Laboratory standards for embryo culture. Culture environments, media systems, and embryologist experience vary significantly between reproductive centers. For the same advanced-age eggs, the probability of forming blastocysts in a high-quality lab can be double. When choosing a center, don't just look at reputation; ask clearly: What is the blastocyst formation rate? Is time-lapse imaging used?
  • Underestimation of the male factor. When the male partner is over 40, sperm DNA fragmentation rates increase, affecting embryo development potential. Both partners in an advanced-age couple should undergo sperm DFI testing. If the fragmentation rate is above 30%, consider pre-treatment optimization or use sperm selection techniques.
  • Individualized luteal phase support. Luteal function is often insufficient in advanced-age women. Adequate and full-course luteal support is needed after transfer, including the route and dosage of progesterone. Some patients have poor absorption of oral progesterone, and switching to vaginal gel or injections can improve implantation rates.
  • Impact of psychological stress on endocrinology. Chronic anxiety elevates cortisol levels, inhibiting gonadotropin secretion and affecting follicular development and endometrial receptivity. This is not a "placebo effect"; there is clear neuroendocrine evidence.

Common Pitfalls to Avoid

In clinical practice, I have seen many advanced-age patients take detours. The following three situations are particularly common:

  • Blindly pursuing the number of eggs retrieved with high-dose stimulation. The response of the advanced-age ovary to FSH is "low quantity, quality-sensitive." High-dose stimulation does not improve egg quality and may instead increase the proportion of chromosomal abnormalities. A more reasonable approach is: moderate dose, gentle stimulation, prioritizing quality.
  • Refusing embryo chromosomal screening. Some patients believe that "if the embryo morphology is good, PGT is not needed." For women over 38, 30-50% of embryos with normal morphology are still chromosomally abnormal. Transferring without screening leads to repeated implantation failure or miscarriage.
  • Excessive preparation, delaying the start of the cycle. The time window for advanced-age patients is very precious. Some women spend six months to a year on traditional Chinese medicine, acupuncture, and dietary adjustments, only to be a year older with a further decline in AMH when they finally start the cycle. Preparation can be done concurrently, but assessment and cycle initiation should not be delayed.

Doctor's Perspective: Decision-Making Logic and Recommendations

When assessing whether an advanced-age patient is suitable for IVF and which strategy to use, I focus on three core dimensions: ovarian reserve (quantity), egg quality (indirectly reflected by age), and the patient's risk tolerance.

When is it suitable to start IVF immediately?
Age 38-42, AMH ≥ 0.8 ng/mL, antral follicle count ≥ 4, no significant uterine abnormalities. These patients have a higher probability of obtaining chromosomally normal embryos. It is recommended to proceed directly with an ovarian stimulation cycle while arranging PGT-A.

When is diagnostic egg retrieval needed first?
Age over 43, or AMH < 0.5 ng/mL. These patients can first undergo one cycle of mild stimulation or natural cycle egg retrieval to see if a blastocyst suitable for biopsy can be formed. If no normal embryos are obtained after 2 consecutive cycles, discuss other options, such as egg donation.

When is it not suitable to proceed with IVF immediately?
Uncontrolled thyroid disease, hypertension, diabetes, or significant uterine pathology (e.g., large endometrial polyps, adhesions, fibroids compressing the endometrium). These conditions need to be addressed first; otherwise, the risk of miscarriage after transfer is high.

Additionally, I repeatedly emphasize to patients: IVF at an advanced age is not a "single decisive battle," but probability management. Setting the goal as "obtaining at least one chromosomally normal embryo and successfully transferring it within 3-4 cycles" is much more realistic than "succeeding in one attempt," and it also helps maintain a more stable mindset.

Frequently Asked Questions

1. Is preparation needed before advanced-age IVF? How long does it take?

Yes, but preparation is not about "improving egg quality," but about "adjusting the body's condition to be optimal for IVF." It is recommended to start 2-3 months in advance with Coenzyme Q10 (400-600mg/day), Vitamin D, and folic acid, while ensuring adequate sleep and moderate exercise. Long-term strict dieting or high-intensity exercise is not recommended. If thyroid dysfunction or Vitamin D deficiency exists, it needs to be corrected first.

2. Can I still do IVF if my AMH is very low?

Low AMH does not mean it's impossible, but the protocol and expectations need adjustment. For patients with AMH < 0.5 ng/mL, a mild stimulation or natural cycle protocol is recommended, aiming to retrieve 1-2 eggs per cycle, accumulate a certain number of embryos, and then perform PGT screening. The overall live birth rate depends on "whether at least one chromosomally normal embryo can be obtained," not on the absolute AMH value.

3. How long does it take from preparation to transfer for advanced-age IVF?

If everything goes smoothly: initial assessment + tests take about 1-2 months, from starting the cycle to egg retrieval takes about 2-3 weeks, embryo culture + PGT screening takes about 4-6 weeks, and pregnancy test is 14 days after transfer. Total time is about 4-6 months. If multiple stimulation cycles are needed to accumulate embryos, the total time can extend to 8-12 months.

4. What are the main risks of advanced-age IVF?

Besides low success rates and high miscarriage rates, advanced-age patients also have a higher risk of poor ovarian response (few eggs retrieved), embryo culture failure, and pregnancy complications (gestational hypertension, diabetes). Additionally, PGT screening itself has a very low misdiagnosis rate (about 1-2%), and prenatal diagnosis is still required after transfer.

5. How to choose a reproductive center?

For advanced-age patients, the laboratory level is more important than the doctor's reputation. It is recommended to prioritize centers that: ① have PGT qualifications; ② have a blastocyst formation rate above 40% (reference value for women under 35); ③ have time-lapse incubators; ④ have an experienced embryology team. You can ask the center to provide cumulative live birth rate data for patients aged 35-40 as a reference.

Doctor's Advice: IVF at an advanced age is a path that requires rational decision-making. Before starting, complete a basic fertility assessment (AMH, FSH, antral follicle count, semen analysis, chromosomal karyotype), and then formulate a cycle plan based on the results. Don't be swayed by stories of "success on the first try." Most successful older patients have gone through 2-3 cycles of accumulation. Focus on "how to obtain a chromosomally normal embryo," rather than worrying about the success rate number itself. If no transferable embryos are obtained after two consecutive cycles, it is recommended to pause and reassess the strategy, including options like egg donation. You don't have to bear all the pressure alone; the doctors and patient education specialists at a formal reproductive center can help you sort things out.

Comments (0)

Leave a Comment